In Me We Trust: Public Health, Personalized Medicine, and the Common Good
By Donna Dickenson,
The Hedgehog Review
| 03. 12. 2014
Half of the population refuses to accept transfusions from public blood banks, trusting blood taken only from a family member or personally banked stocks. Is this just another example of Americans’ ruggedly individualistic distrust of all things public?
You might well think so, but the population in question is European. The finding comes from a Eurobarometer survey of European public opinion, evidence of increasingly transnational misgivings about what sociologist Richard Titmuss described in The Gift Relationship as the quintessential symbol of social solidarity: blood donation. In the wake of a series of scandals in France, Great Britain, and elsewhere in Europe, blood donation is becoming personalized and privatized on a global level.
Another symbol of our common humanity, the human genome, likewise faces the threat of biomedical privatization. The original vision of the human genome was communitarian. It was seen to be the common property of humanity. Article 1 of the UNESCO Universal Declaration on the Human Genome and Human Rights, issued in 1997, states that “the human genome underlines the fundamental unity of all members of the human family...
Related Articles
By Evelina Johansson Wilén, Jacobin | 01.18.2026
In her book The Argonauts, Maggie Nelson describes pregnancy as an experience marked by a peculiar duality. On the one hand, it is deeply transformative, bodily alien, sometimes almost incomprehensible to the person undergoing it. On the other hand...
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By Paula Siverino Bavio, BioNews | 01.12.2026
For more than ten years, gestational surrogacy in Uruguay existed in a state of legal latency: provided for by law, carefully regulated as an exception, yet without a single birth to make it real.
That situation changed with the arrival...